Clinic
Ashe Pediatrics
Ashe Pediatrics was paid $2.72M by Medicaid between Apr 2019 and Dec 2024, across 64 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoASHE PEDIATRICS
WEST JEFFERSON, NC 28694
WEST JEFFERSON, NC 28694
33aNPI1790078038assigned 05/19/2011
33bProvider typePrimary Care Clinic/Center
28Total paid$2.72M
24GClaims102,230
24DCodes billed64
24AFirst – last monthApr 2019 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in North Carolina
Rank by total paid#13 of 116
Median peer was paid$226K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 9,363 | $268K | |
| 2020 | 10,996 | $443K | |
| 2021 | 19,264 | $628K | |
| 2022 | 29,441 | $731K | |
| 2023 | 25,395 | $567K | |
| 2024incomplete | 7,771 | $81K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 10,819 | 7,776 | $837K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 5,596 | 4,229 | $291K |
| 99199 | Unlisted special service, procedure or report | 6.8% | 35,417 | 24,502 | $184K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 6.5% | 989 | 640 | $176K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.2% | 5,478 | 4,047 | $142K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.6% | 1,245 | 967 | $124K |
| 87428 | 4.3% | 2,232 | 1,612 | $116K | |
| 99443 | 4.2% | 1,785 | 1,354 | $115K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.1% | 1,108 | 937 | $85K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.6% | 903 | 755 | $71K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.2% | 3,294 | 2,749 | $60K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.1% | 662 | 544 | $56K |
52 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.9% | 865 | $51K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.8% | 1,509 | $49K |
| 99442 | 1.5% | 903 | $40K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 1,110 | $38K |
| 99401 | 1.4% | 1,325 | $37K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,814 | $27K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 301 | $23K |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | <1% | 672 | $20K |
| 92587 | <1% | 796 | $20K | |
| 96127 | <1% | 3,465 | $18K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,413 | $18K |
| 92552 | <1% | 2,039 | $17K | |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | <1% | 773 | $17K |
| 94664 | <1% | 1,194 | $12K | |
| 88738 | <1% | 1,942 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 886 | $9K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 296 | $9K |
| 80061 | Lipid panel | <1% | 598 | $8K |
| 0071A | <1% | 61 | $4K | |
| 99173 | <1% | 2,686 | $4K | |
| 90651 | <1% | 137 | $3K | |
| 0072A | <1% | 42 | $3K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 77 | $3K |
| 90686 | <1% | 1,756 | $2K | |
| E0570 | Nebulizer, with compressor | <1% | 14 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 805 | $2K |
| 90734 | <1% | 49 | $2K | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 1,091 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 61 | $1K |
| 92567 | <1% | 787 | $1K | |
| 99417 | Prolong home eval add 15m | <1% | 13 | $1K |
| 87807 | <1% | 97 | $1K | |
| 90621 | <1% | 15 | $1K | |
| D1206 | Topical application of fluoride varnish | <1% | 77 | $1K |
| 85018 | <1% | 675 | $941.39 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 138 | $672.75 |
| 83655 | <1% | 67 | $660.68 | |
| 87634 | <1% | 15 | $393.12 | |
| 99441 | <1% | 12 | $346.08 | |
| 90474 | <1% | 15 | $322.05 | |
| 99051 | <1% | 19 | $291.28 | |
| 81002 | <1% | 138 | $245.59 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 86 | $192.37 |
| 96161 | <1% | 27 | $106.11 | |
| 90633 | <1% | 81 | $103.92 | |
| 90619 | <1% | 34 | $11.55 | |
| 91307 | <1% | 160 | $11.02 | |
| 36416 | <1% | 1,399 | $10.50 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 76 | $0.15 |
| 96160 | 0% | 16 | $0.00 | |
| 90670 | 0% | 60 | $0.00 | |
| 90680 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTRICKLAND, DANIEL (DIRECTOR)
Parent organizationWJ MEDICAL ASSOC